Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Non-Current Deferred Tax Liability (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Non-Current Deferred Tax Liability for 6 consecutive years, with $1.1 million as the latest value for Q3 2018.

  • Quarterly Non-Current Deferred Tax Liability changed 0.0% to $1.1 million in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Sep 2018, changed 0.0% year-over-year, with the annual reading at $1.1 million for FY2017, 53.16% down from the prior year.
  • Non-Current Deferred Tax Liability hit $1.1 million in Q3 2018 for Armata Pharmaceuticals, roughly flat from $1.1 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $3.1 million in Q1 2014 to a low of $1.1 million in Q2 2017.
  • Historically, Non-Current Deferred Tax Liability has averaged $2.4 million across 5 years, with a median of $3.0 million in 2015.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: changed 0.0% in 2014 and later tumbled 61.83% in 2017.
  • Year by year, Non-Current Deferred Tax Liability stood at $3.1 million in 2014, then decreased by 2.37% to $3.0 million in 2015, then fell by 18.5% to $2.4 million in 2016, then tumbled by 53.16% to $1.1 million in 2017, then changed by 0.0% to $1.1 million in 2018.
  • Business Quant data shows Non-Current Deferred Tax Liability for ARMP at $1.1 million in Q3 2018, $1.1 million in Q2 2018, and $1.1 million in Q1 2018.